WHO ICTRP trial
Comparing the efficacy of bupropion and amantadine on sexual dysfunction induced…
IRCT201409275280N17 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201409275280N17 |
|---|---|
| Public title | Comparing the efficacy of bupropion and amantadine on sexual dysfunction induced by a selective serotonin reuptake inhibitor |
| Scientific title | Comparing the efficacy of bupropion and amantadine on sexual dysfunction induced by a selective serotonin reuptake inhibitor |
| Primary sponsor | Vice Chancellor for research of Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Sexual dysfunction. Sexual dysfunction, not caused by organic disorder or disease;Sexual dysfunction, not caused by organic disorder or disease |
| Interventions | Intervention 1: The patients were given bupropion 200mg/day for the period of4 weeks. Intervention 2: patients were assigned to another group and were given amantadine 200 mg/day for the period of4 weeks.;Treatment - Drugs;Treatment… |
| Registration date | Oct 27, 2014 |
| Target size | 38 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: